ID   YU-1097
AC   CVCL_C8UL
DR   Wikidata; Q123033987
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys797Ser (c.2389T>A); ClinVar=VCV000376342; Zygosity=Unspecified (PubMed=31882684).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=31882684).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Deep exome analysis.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=31882684; DOI=10.1038/s41598-019-56356-4; PMCID=PMC6934824;
RA   Kim S.-Y., Lee J.Y., Kim D.H., Joo H.-S., Yun M.R., Jung D., Yun J.,
RA   Heo S.G., Ahn B.-C., Park C.W., Pyo K.H., Chun Y.J., Hong M.H.,
RA   Kim H.R., Cho B.C.;
RT   "Patient-derived cells to guide targeted therapy for advanced lung
RT   adenocarcinoma.";
RL   Sci. Rep. 9:19909-19909(2019).
//